Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats

Archives of Pharmacal Research

Volumn 32, Issue 3, 2009, Pages 353-358

  Choi, Seul Min ^a   Seo, Mi Jeong ^a   Kang, Kyung Koo ^a   Kim, Jeong Hoon ^a   Ahn, Byoung Ok ^a   Yoo, Moohi ^a  

^a Dong A Pharmaceutical Company   (South Korea)

Author keywords

Amlodipine; Combination; Losartan; Spontaneously hypertensive rat; Systolic blood pressure

Indexed keywords

AMLODIPINE; COLLAGEN; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; MALE; MONOTHERAPY; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ACETYLCHOLINE; ADMINISTRATION, ORAL; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; CARDIOMEGALY; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HYPERTENSION; LOSARTAN; MYOCARDIUM; RATS; RATS, INBRED SHR; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 65449162729     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1307-x     Document Type: Article

References (21)

1. R. Berkels D. Taubert H. Bartels T. Breitenbach W. Klaus R. Roesen 2004 Amlodipine increases endothelial nitric oxide by dual mechanisms Pharmacology 70 39 45
2. A. V. Chobanian G. L. Bakris H. R. Black W. C. Cushman L. A. Green J. L. Izzo Jr D. W. Jones B. J. Materson S. Oparil J. T. Wright Jr E. J. Roccella 2003 Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 1206 1252
3. L. V. d'Uscio S. Shaw M. Barton T. F. Luscher 2003 Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: Role of blood pressure and endothelial function Hypertension 31 1305 1310
4. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J. Hypertens. 21 1011 1053
5. F. Franzoni G. Santoro F. Regoli Y. Plantinga F. R. Femia A. Carpi F. Galetta 2004 An in vitro study of the peroxyl and hydroxyl radical scavenging capacity of the calcium antagonist amlodipine Biomed. Pharmacother. 58 423 426
6. I. Gavras T. Rosenthal 2004 Combination therapy as first-line treatment for hypertension Curr. Hypertens. Rep. 6 267 272
7. N. Gokhale S. Shahani D. Pawar 2002 Efficacy and safety of losartan-amplodipine combination-an Indian postmarketing surveillance experience J. Indian Med. Assoc. 100 207 208
8. O. Kohlmann Jr W. Oigman D. Mion Jr J.C. Rocha M.A. Gomes N. Salgado G. S. Feitosa E. Dallaverde A.B. Ribeiro 2006 The "LOTHAR" study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension Arq. Bras. Cardiol. 86 39 51
9. L. H. Lindholm H. Ibsen B. Dahlof R. B. Devereux G. Beevers U. de Faire F. Fyhrquist S. Julius S. E. Kjeldsen K. Kristiansson O. Lederballe-Pedersen M. S. Nieminen P. Omvik S. Oparil H. Wedel P. Aurup J. Edelman S. Snapinn 2002 Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 1004 10
10. R. Maeso E. Rodrigo R. Munoz-Garcia J. Navarro-Cid L. M. Ruilope V. Cachofeiro V. Lahera 1998 Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR Kidney Int. Suppl. 68 S30 S35
11. N. Makino M. Sugano S. Otsuka T. Hata 1997 Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats Hypertension 30 796 802
12. B. J. Materson D. J. Reda W. C. Cushman B. M. Massie E. D. Freis M. S. Kochar R. J. Hamburger C. Fye R. Lakshman J. Gottdiener 1993 Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The department of veterans affairs cooperative study group on antihypertensive agents N. Engl. J. Med. 328 914 921
13. N. Okuda T. Hayashi T. Mori S. Inamoto M. Okabe S. Mieno H. Horimoto Y. Kitaura 2005 Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure Hypertens. Res. 28 431 438
14. Y. K. On C. H. Kim B. H. Oh M. M. Lee Y. B. Park 2002 Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension Hypertens. Res. 25 365 371
15. T. Rosenthal I. Gavras 2006 Fixed-drug combinations as first-line treatment for hypertension Prog. Cardiovasc. Dis. 48 416 425
16. I. H. Schulman M. Zachariah L. Raij 2005 Calcium channel blockers, endothelial dysfunction, and combination therapy Aging Clin. Exp. Res. 17 4Suppl 40 45
17. M. A. Sevilla F. Voces R. Carron E. I. Guerrero N. Ardanaz L. San Román M. A. Arévalo M. J. Montero 2004 Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal Life Sci. 75 881 891
18. 2+ antagonists on left ventricle hypertrophy and coronary changes in spontaneously hypertensive rats J. Cardiovasc. Pharmacol. 41 544 552
19. J. A. Whitworth 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J. Hypertens. 21 1983 1992
20. K. Yao H. Sato Y. Ina K. Suzuki T. Ohno S. Shirakura 2003 Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats Hypertens. Res. 26 635 641
21. K. Yao H. Sato R. Sonoda Y. Ina K. Suzuki T. Ohno 2003 Effects of benidipine and candesartan on kidney and vascular function in hypertensive Dahl rats Hypertens. Res. 26 569 76